Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126403492 | 12640349 | 2 | F | 20160528 | 20160816 | 20160810 | 20160818 | EXP | FR-BAYER-2016-151383 | BAYER | 89.00 | YR | E | F | Y | 0.00000 | 20160818 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126403492 | 12640349 | 1 | PS | ASPIRINE PROTECT 100 MG COMPRIM? GASTRO-R?SISTANT | ASPIRIN | 1 | Oral | 100 MG, QD | 21317 | 100 | MG | GASTRO-RESISTANT TABLET | QD | ||||||
| 126403492 | 12640349 | 2 | SS | ASPIRINE PROTECT 100 MG COMPRIM? GASTRO-R?SISTANT | ASPIRIN | 1 | 21317 | GASTRO-RESISTANT TABLET | |||||||||||
| 126403492 | 12640349 | 3 | SS | Previscan | FLUINDIONE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 126403492 | 12640349 | 4 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
| 126403492 | 12640349 | 5 | C | Lasilix | FUROSEMIDE | 1 | 40 MG, UNK | 0 | 40 | MG | TABLET | ||||||||
| 126403492 | 12640349 | 6 | C | Amiodarone | AMIODARONE | 1 | 0 | ||||||||||||
| 126403492 | 12640349 | 7 | C | Cardensiel | BISOPROLOL FUMARATE | 1 | 1.25 MG, UNK | 0 | 1.25 | MG | COATED TABLET | ||||||||
| 126403492 | 12640349 | 8 | C | Vasten | PRAVASTATIN SODIUM | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET | ||||||||
| 126403492 | 12640349 | 9 | C | Amlor | AMLODIPINE BESYLATE | 1 | 10 MG, UNK | 0 | 10 | MG | CAPSULE | ||||||||
| 126403492 | 12640349 | 10 | C | Levothyrox | LEVOTHYROXINE | 1 | 50 ?G, UNK | 0 | 50 | UG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126403492 | 12640349 | 1 | Atrial fibrillation |
| 126403492 | 12640349 | 2 | Aortic valve stenosis |
| 126403492 | 12640349 | 3 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126403492 | 12640349 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126403492 | 12640349 | Anaemia | |
| 126403492 | 12640349 | Gastrointestinal haemorrhage | |
| 126403492 | 12640349 | International normalised ratio increased | |
| 126403492 | 12640349 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126403492 | 12640349 | 1 | 20160529 | 0 | ||
| 126403492 | 12640349 | 3 | 20160529 | 0 |